Nutriband Inc. is a pharmaceutical and healthcare company that specializes in the development, manufacturing, and marketing of innovative transdermal patches and oral thin films. The company was founded in 2008 and is headquartered in Orlando, Florida, USA. Nutriband is a publicly traded company and is listed on the OTCQB market under the ticker symbol "NTRB."
Nutriband's core focus is on providing convenient and effective drug delivery solutions through its transdermal patches and oral thin films. Transdermal patches are patches applied to the skin that deliver medication directly into the bloodstream, offering a non-invasive and controlled method of drug administration. Oral thin films are dissolvable films that deliver medication when placed on or under the tongue. Nutriband's patches are designed to address various therapeutic areas, including pain management, hormone replacement, and motion sickness. These patches provide a convenient and discreet way for patients to receive medication without the need for injections or pills.
The company works closely with pharmaceutical companies, contract manufacturers, and research organizations to develop and commercialize its products. By partnering with industry leaders, Nutriband can access additional resources, expertise, and distribution channels to expand its market reach.
Nutriband's vision is to make a positive impact on global health by providing innovative drug delivery solutions that improve patient well-being. The company is dedicated to adhering to stringent quality standards and regulatory requirements to ensure the safety and efficacy of its products.